Skip to content
+44 (0)203 764 9530 avillion@avillionllp.com Contact

Avillion

  • Partnerships
  • An Innovative Model
  • The Team
  • Business Opportunity
  • Our Investors
  • News

News

Latest News

27Mar
2017

Avillion Strengthens Clinical and Regulatory Development Capabilities with the Appointment of Mark Weinberg as Chief Medical Officer

06Dec
2016

Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia

15Sep
2015

Avillion Announces Completion of Enrolment in Phase III BFORE Trial to Assess BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia

06May
2014

Avillion announces royalty pharmaceutical investment

18Feb
2014

Avillion appoints Dr Allison Jeynes-Ellis as chief executive officer

09Jan
2014

Avillion group partners with Pfizer to co-develop Bosulif (bosutinib) as first-line treatment

Previous 1 2 3 4

Categories

  • Deals
  • Delivered & milestones achieved
  • Other
  • People
  • Uncategorized

News Archive

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

Avillion

  • Partnerships
  • Governance
  • Areas of interest
  • An Innovative Model
  • Operational Excellence
  • Study Delivery
  • Case Study
  • Business Opportunity
  • What we do
  • Global outreach
  • Frequently Asked Questions

Contact

+44 (0)203 764 9530 avillion@avillionllp.com Linkedin

© Avillion LLP. Registered in England and Wales No: OC379058

Privacy Policy | Cookie Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cookie Overview

Cookies are small text files that are placed on your device when you visit a website. Cookies may be used to keep track of pages visited within the site, help you continue where you left off or remember your preferences, such as language settings.
Cookies help us to make online services easier to use, monitor the use of our site and help us improve the service provided to you.

TYPES OF COOKIES
Cookies can be “persistent” or “session” cookies. Persistent cookies remain on your device for a period of time when you go offline, while session cookies are deleted as soon as you close your web browser.

COOKIE PREFERECNES
You may change your preferences at any time or withdraw your consent for each cookie category - except Required cookies using this website’s cookie setting option.

Required Cookies

Required cookies (persistent) should be enabled at all times so that we can save your cookie preferences.

These cookies are essential to enable you to move around the website and use its features.

Operational Cookies

These cookies (which can be persistent or session) collect information about how visitors use a website, for instance which pages visitors go to most often and if they receive error messages. They are used to improve how a website works in future versions, e.g. Google Analytics, Microsoft Clarity.

Please enable required cookies first so that we can save your preferences!

Privacy Policy

More information about our Privacy Policy